Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A
As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
If You Could Only Hold 3 Investments for Life, Consider These
Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth. 
Via MarketBeat
Topics ETFs Economy Retirement
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, TGI, AVAV, NARI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Demystifying Inari Medical: Insights From 6 Analyst Reviews ↗
 
Via Benzinga
News headline image
Key Takeaways From Inari Medical Analyst Ratings ↗
 
Via Benzinga
News headline image
Inari Medical's Earnings: A Preview ↗
 
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, NARI, VTS, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NARI, QTRX, CTV on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HEES, NARI, SSTK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: H&E Equipment Services, Inc. (Nasdaq - HEES), Inari Medical, Inc. (Nasdaq - NARI), Paycor HCM, Inc. (Nasdaq - PYCR), Shutterstock, Inc. (NYSE - SSTK)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio? 
Via Benzinga
News headline image
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NEUE, VCSA, SSTK, NARI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position ↗
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach. 
Via Benzinga
News headline image
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
NARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Inari Medical Catapults 30% On Rumored Stryker Takeover ↗
Inari is best-known for its series of catheter-like devices that remove blood clots. 
Via Investor's Business Daily
News headline image
Inari Medical to Present at the J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
Inari Medical Stock Gets RS Rating Upgrade ↗
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily
News headline image
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan 
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
Inari Medical Announces Joint Venture in Greater China
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
Inari Medical to Participate in the Jefferies London Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization 
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Inari Medical Reports Third Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
News headline image
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
From Inari Medical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.